15396-41-5 Usage
General Description
2,3,5-triiodo-benzoic acid methyl ester is a chemical compound with the molecular formula C8H5I3O2. It is commonly used in the medical and pharmaceutical industries as a contrast agent for imaging techniques such as X-ray, CT scans, and MRI. 2,3,5-triiodo-benzoic acid methyl ester contains three iodine atoms, which help to enhance the visibility and contrast of certain tissues and organs in medical imaging. It is also utilized in the production of diagnostic reagents and chemical intermediates for the synthesis of various pharmaceutical compounds. Due to its properties and applications, 2,3,5-triiodo-benzoic acid methyl ester is an important and widely used chemical compound in the field of medical diagnostics and research.
Check Digit Verification of cas no
The CAS Registry Mumber 15396-41-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,3,9 and 6 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 15396-41:
(7*1)+(6*5)+(5*3)+(4*9)+(3*6)+(2*4)+(1*1)=115
115 % 10 = 5
So 15396-41-5 is a valid CAS Registry Number.
15396-41-5Relevant articles and documents
Delivery of x-ray contrast agents using receptor mediated endocytosis
-
, (2008/06/13)
The invention provides a method of targeting an x-ray contrast agent to a specific population of cells or organ. Targeting may be accomplished by forming a complex of a radiopaque label with a saccharide capable of interacting with a cell receptor. The resulting complex may then be internalized into the specific population of cells or organ by receptor mediated endocytosis. In one embodiment of the invention, the radiopaque label may include a compound containing iodine and the saccharide may include arabinogalactan, galactan, or derivatives thereof. The invention provides a method for determining the metabolic viability or disease state of the target cells or organ by visualizing the extent, mode of uptake and excretion of the targeted x-ray contrast agent by x-ray or computer tomography.
